A Phase II Study of Intravenous Rexin-G in Recurrent or Metastatic Osteosarcoma.
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2011
At a glance
- Drugs Rexin-G (Primary)
- Indications Osteosarcoma
- Focus Registrational; Therapeutic Use
- 09 Jun 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 09 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2010 Planned end date changed from 1 Dec 2008 to 1 Dec 2010 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History